Lundbeckfond Ventures

Lundbeckfonden BioCapital operates as an evergreen venture capital fund, strategically investing in promising life science companies. Its core activity involves providing capital and support to facilitate the translation and commercialization of groundbreaking scientific discoveries, with a particular focus on biopharmaceuticals and the broader healthcare sector. The firm’s approach emphasizes long-term growth and impact within its portfolio.

The entity was established in the autumn of 2009, wholly owned by The Lundbeck Foundation. This structure reflects a strategic decision by the Foundation to actively support the biotechnology ecosystem and foster innovation. The founding insight centered on leveraging the Foundation’s resources to bridge the gap between scientific research and its practical application in new treatments and technologies.

The fund’s investments primarily target life science companies, especially those based in Europe, which benefit from both financial backing and active collaboration. Lundbeckfonden BioCapital’s overarching mission is to advance health and well-being by ensuring that cutting-edge scientific advancements reach the market and ultimately benefit patients worldwide, shaping the future of medicine.